PEDIATRIC FLU VACCINES 2024-2025

Contract Award won by GLAXOSMITHKLINE, LLC
No current value reported
RecipientGLAXOSMITHKLINE, LLC UEI FRHTPHMZMX47
Award ID75D30124D18410
Award amountNo current value reported
Award type—
Awarding agencyDepartment of Health and Human Services — Centers for Disease Control and Prevention
NAICS325411 — MEDICINAL AND BOTANICAL MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateJan 2, 2024
End date—
Place of performance—
Record updatedApr 29, 2024

View the official award record

More awards won by GLAXOSMITHKLINE, LLC

:COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES
Department of Defense · $1,596,901,996 · Nov 15, 2021
GLAXOSMITHKLINE ADJUVANT AS03
Department of Defense · $346,055,756 · Jul 30, 2020
:COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
Department of Defense · $279,862,800 · Sep 24, 2021
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Department of Health and Human Services · $45,499,950 · Sep 30, 2025
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.
Department of Health and Human Services · $22,877,697 · Sep 14, 2022

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids